c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module Increasing intratumor C/EBP-β LIP and
Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports CCAAT Enhancer Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding Research C EBP regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages Science Immunology C EBP beta Antibody Cell Signaling Technology C EBP: The structure, regulation, and its roles in inflammation related diseases ScienceDirect
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




